does tirzepatide affect liver enzymes A Rare Case of Tirzepatide-Induced Hepatitis: Causality Assessment With the RUCAM Criteria Beyond Weight Loss: Comparative Effects

During the mean observation period of 3.3 years, semaglutide at 2.4 mg per week resulted in a mean weight loss of 9.39% from baseline and a 20% reduction in the risk of MACE (HR 0.80, 95% CI 0.720.90), especially a 28% reduction in the risk of myocardial infarction (HR 0.72, 95% CI 0.610.85), compared with that in the placebo group

Some may notice improvements in energy or skin clarity within a few weeks, while deeper benefits may take longer and can accumulate over 6 to 12 months of consistent use

Timelines vary and treatment is never guaranteed

One key area it targets is the muscle that runs vertically along the front of the neck, which weakens with age